Cargando…

Development of a pharmaceutical care program in progressive stages in geriatric institutions

BACKGROUND: To introduce and manage a Pharmaceutical care programs in geriatric care institutions presents difficulties such as reduced pharmacy service staff, complexity of the patients or lack of integration of the pharmacist in the health care team. This work describes the evolution of the implem...

Descripción completa

Detalles Bibliográficos
Autores principales: Mestres, Conxita, Hernandez, Marta, Agustí, Anna, Puerta, Laura, Llagostera, Blanca, Amorós, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300022/
https://www.ncbi.nlm.nih.gov/pubmed/30567496
http://dx.doi.org/10.1186/s12877-018-1002-1
_version_ 1783381610418143232
author Mestres, Conxita
Hernandez, Marta
Agustí, Anna
Puerta, Laura
Llagostera, Blanca
Amorós, Patricia
author_facet Mestres, Conxita
Hernandez, Marta
Agustí, Anna
Puerta, Laura
Llagostera, Blanca
Amorós, Patricia
author_sort Mestres, Conxita
collection PubMed
description BACKGROUND: To introduce and manage a Pharmaceutical care programs in geriatric care institutions presents difficulties such as reduced pharmacy service staff, complexity of the patients or lack of integration of the pharmacist in the health care team. This work describes the evolution of the implementations of a program of pharmaceutical care centered in drug related problems (DRP) in a group of geriatric institutions of different levels of complexity. METHODS: Setting: Long-term and subacute care hospitals (HSS) and Health care teams attending nursing homes (EARs). Participants: Patients attended in HSS and EARs during different periods between 2010 and 2016. Interventions: The program was developed in different stages, in which pharmacists made interventions of increasing complexity. RESULTS: Between 2010 and 2013, the approach was only to improve the prescription of non-appropriate drugs for the elderly, which was reduced from 19 to 14.5%. Subsequent steps included detection of drug-related problems (DRP), systematization of treatment revisions, recording of pharmacist interventions, improvements in the classification of interventions and the creation of a web-based database for recording in a more efficient way. During these years, there was an increase in the number of patients included in pharmaceutical care activities and thus the number of pharmacist interventions (3872 in 2014 vs 5903 in 2016). In 2016, mean age in 2016: 83.2 years old. Mean number of medicines/patient: 8.4 ± 3.3, and mean interventions/patient: 1.62. Degree of acceptance of the interventions by physicians improved (68.6% in 2016 vs 45.5% in 2012), even though there is still much work to do. The Medication Appropriateness Index (MAI) showed that when the interventions were accepted, there was an important improvement. HSS mean MAI values pre-intervention: 2.52, post-intervention 0.80. In EARs: 5 pre and 1.39 post. In both cases p < 0.0001. CONCLUSIONS: Approaching the deployment of activities in a progressive way has made us more efficient and able to confront and solve the problems that have arisen. Even though there has been a very restricted increase in the staff and budget, we are able to implement a DRP detection programme with guaranties of quality.
format Online
Article
Text
id pubmed-6300022
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63000222018-12-20 Development of a pharmaceutical care program in progressive stages in geriatric institutions Mestres, Conxita Hernandez, Marta Agustí, Anna Puerta, Laura Llagostera, Blanca Amorós, Patricia BMC Geriatr Research Article BACKGROUND: To introduce and manage a Pharmaceutical care programs in geriatric care institutions presents difficulties such as reduced pharmacy service staff, complexity of the patients or lack of integration of the pharmacist in the health care team. This work describes the evolution of the implementations of a program of pharmaceutical care centered in drug related problems (DRP) in a group of geriatric institutions of different levels of complexity. METHODS: Setting: Long-term and subacute care hospitals (HSS) and Health care teams attending nursing homes (EARs). Participants: Patients attended in HSS and EARs during different periods between 2010 and 2016. Interventions: The program was developed in different stages, in which pharmacists made interventions of increasing complexity. RESULTS: Between 2010 and 2013, the approach was only to improve the prescription of non-appropriate drugs for the elderly, which was reduced from 19 to 14.5%. Subsequent steps included detection of drug-related problems (DRP), systematization of treatment revisions, recording of pharmacist interventions, improvements in the classification of interventions and the creation of a web-based database for recording in a more efficient way. During these years, there was an increase in the number of patients included in pharmaceutical care activities and thus the number of pharmacist interventions (3872 in 2014 vs 5903 in 2016). In 2016, mean age in 2016: 83.2 years old. Mean number of medicines/patient: 8.4 ± 3.3, and mean interventions/patient: 1.62. Degree of acceptance of the interventions by physicians improved (68.6% in 2016 vs 45.5% in 2012), even though there is still much work to do. The Medication Appropriateness Index (MAI) showed that when the interventions were accepted, there was an important improvement. HSS mean MAI values pre-intervention: 2.52, post-intervention 0.80. In EARs: 5 pre and 1.39 post. In both cases p < 0.0001. CONCLUSIONS: Approaching the deployment of activities in a progressive way has made us more efficient and able to confront and solve the problems that have arisen. Even though there has been a very restricted increase in the staff and budget, we are able to implement a DRP detection programme with guaranties of quality. BioMed Central 2018-12-19 /pmc/articles/PMC6300022/ /pubmed/30567496 http://dx.doi.org/10.1186/s12877-018-1002-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mestres, Conxita
Hernandez, Marta
Agustí, Anna
Puerta, Laura
Llagostera, Blanca
Amorós, Patricia
Development of a pharmaceutical care program in progressive stages in geriatric institutions
title Development of a pharmaceutical care program in progressive stages in geriatric institutions
title_full Development of a pharmaceutical care program in progressive stages in geriatric institutions
title_fullStr Development of a pharmaceutical care program in progressive stages in geriatric institutions
title_full_unstemmed Development of a pharmaceutical care program in progressive stages in geriatric institutions
title_short Development of a pharmaceutical care program in progressive stages in geriatric institutions
title_sort development of a pharmaceutical care program in progressive stages in geriatric institutions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300022/
https://www.ncbi.nlm.nih.gov/pubmed/30567496
http://dx.doi.org/10.1186/s12877-018-1002-1
work_keys_str_mv AT mestresconxita developmentofapharmaceuticalcareprograminprogressivestagesingeriatricinstitutions
AT hernandezmarta developmentofapharmaceuticalcareprograminprogressivestagesingeriatricinstitutions
AT agustianna developmentofapharmaceuticalcareprograminprogressivestagesingeriatricinstitutions
AT puertalaura developmentofapharmaceuticalcareprograminprogressivestagesingeriatricinstitutions
AT llagosterablanca developmentofapharmaceuticalcareprograminprogressivestagesingeriatricinstitutions
AT amorospatricia developmentofapharmaceuticalcareprograminprogressivestagesingeriatricinstitutions